Literature DB >> 17120874

Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003.

Tara L Schellenberg1, Maureen E Anderson, Michael A Drebot, Mark T R Vooght, A Ross Findlater, Phillip S Curry, C Alexia Campbell, William D Osei.   

Abstract

BACKGROUND: The Five Hills Health Region of Saskatchewan reported the highest West Nile virus (WNV) case rates in the 2003 outbreak. A serologic and telephone survey was undertaken to assess the seroprevalence of the virus and the knowledge, attitudes and behaviours of the residents.
METHODS: Respondents had to be at least 18 years of age, and residents of the Five Hills Health Region between July 1st and September 15th, 2003. Blood samples of respondents were tested at the National Microbiology Laboratory for flavivirus immunoglobulin using a WNV IgG ELISA and plaque reduction neutralization test. Descriptive analyses performed related to respondents' demographics, knowledge, attitudes, behaviours, and seropositivity. WNV infection risk was assessed using odds ratio.
RESULTS: There were 619 questionnaire respondents, of whom 501 donated a blood sample. The seroprevalence of WNV in the Five Hills Health Region was 9.98% (95% CI 7.37-12.59%). Seropositivity of rural areas was 16.8% and urban was 3.2%. Most (97%) of participants thought WNV was an important health issue. Forty-eight percent of the participants used insect repellents containing DEET most of the time. There was good knowledge regarding WNV transmission and prevention of the spread of WNV. Rural compared to urban residents were six times more likely to be positive for WNV (OR=6.13, 95% CI 2.82-13.34).
INTERPRETATION: This is the highest seroprevalence rate of West Nile virus recorded in North America thus far. Many factors could have influenced this outbreak, such as eco-region, early prolonged hot weather, level of mosquito control programs, urban and rural community differences, and personal protective behaviours.

Entities:  

Mesh:

Year:  2006        PMID: 17120874

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  6 in total

1.  Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease.

Authors:  Suzanne M Tomlinson; Stanley J Watowich
Journal:  Biochemistry       Date:  2008-10-15       Impact factor: 3.162

2.  West Nile virus in Canada: ever-changing, but here to stay.

Authors:  H Zheng; M A Drebot; M B Coulthart
Journal:  Can Commun Dis Rep       Date:  2014-05-15

3.  Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008.

Authors:  Paul J Carson; Stephanie M Borchardt; Brian Custer; Harry E Prince; Joan Dunn-Williams; Valerie Winkelman; Leslie Tobler; Brad J Biggerstaff; Robert Lanciotti; Lyle R Petersen; Michael P Busch
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

4.  The First Case Report of West Nile Virus-Induced Acute Flaccid Quadriplegia in Canada.

Authors:  Yahya Salim Yahya Al-Fifi; Kamran Kadkhoda; Mike Drebot; Beverly Wudel; E J Bow
Journal:  Case Rep Infect Dis       Date:  2018-07-15

5.  West Nile virus infection in plasma of blood and plasma donors, United States.

Authors:  Christina B Planitzer; Jens Modrof; Mei-ying W Yu; Thomas R Kreil
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

Review 6.  Major emerging vector-borne zoonotic diseases of public health importance in Canada.

Authors:  Manisha A Kulkarni; Lea Berrang-Ford; Peter A Buck; Michael A Drebot; L Robbin Lindsay; Nicholas H Ogden
Journal:  Emerg Microbes Infect       Date:  2015-06-10       Impact factor: 7.163

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.